Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
40%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
IHE
55
HOLDINGS
28%
ALSO IN FTXH
FTXH
51
HOLDINGS
28%
ALSO IN IHE
SECTOR DRIFT (IHE minus FTXH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
| ELI LILLY & CO | 23.5% | 7.3% | 7.3% | |
| JOHNSON & JOHNSON | 22.7% | 7.2% | 7.2% | |
| PFIZER INC | 4.6% | 7.1% | 4.6% | |
| MERCK & CO. INC. | 4.5% | 7.1% | 4.5% | |
| VIATRIS, INC. | 4.5% | 3.8% | 3.8% | |
IHE Overweight Relative to FTXH
| ELI LILLY & CO | 16.3% | |
| JOHNSON & JOHNSON | 15.5% | |
| ROYALTY PHARMA PLC CLASS A | 4.3% | |
| CORCEPT THERAPEUTICS INC | 1.9% | |
| AXSOME THERAPEUTICS, INC. | 1.9% | |
| ELANCO ANIMAL HEALTH, INC. | 1.3% | |
| ZOETIS INC | 1.1% | |
| DEFINIUM THERAPEUTICS INC | 1.1% | |
| BRISTOL-MYERS SQUIBB CO | 1.0% | |
| VERADERMICS INC | 0.8% |
IHE Underweight Relative to FTXH
| ABBVIE INC | -7.3% | |
| BIOGEN IDEC INC | -3.7% | |
| GILEAD SCIENCES INC | -3.7% | |
| INCYTE CORP | -3.5% | |
| REGENERON PHARMACEUTICALS | -3.5% | |
| VERTEX PHARMACEUTICALS INC | -3.4% | |
| AMGEN INC | -3.4% | |
| UNITED THERAPEUTICS CORP | -2.9% | |
| MERCK & CO. INC. | -2.6% | |
| PFIZER INC | -2.5% |